Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Loveman

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Endocrinology|November 14, 2002
Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adultsJ Bryant, E Loveman, C Cave, et al.
Health Technology Assessment (Winchester, England)|October 23, 2009
Ustekinumab for the treatment of moderate to severe psoriasisE Gospodarevskaya, J Picot, K Cooper, et al.
Health Technology Assessment (Winchester, England)|October 4, 2008
Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic reviewA Takeda, E Loveman, P Harris, et al.
The Cochrane Database of Systematic Reviews|October 20, 2005
Surgery for morbid obesityJ Colquitt, A Clegg, E Loveman, et al.
Health Technology Assessment (Winchester, England)|September 19, 2003
The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluationE Loveman, C Cave, C Green, et al.
Health Technology Assessment (Winchester, England)|April 2, 2010
The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluationE Loveman, J Jones, D Hartwell, et al.
Health Technology Assessment (Winchester, England)|October 7, 2009
Gemcitabine for the treatment of metastatic breast cancerJ Jones, A Takeda, S C Tan, et al.
Health Technology Assessment (Winchester, England)|April 28, 2007
The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluationA L Takeda, J Jones, E Loveman, et al.
Health Technology Assessment (Winchester, England)|August 28, 2002
The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluationA J Clegg, J Colquitt, M K Sidhu, et al.
Health Technology Assessment (Winchester, England)|February 14, 2003
Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluationJ Bryant, E Loveman, D Chase, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Endocrinology|November 14, 2002
Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adultsJ Bryant, E Loveman, C Cave, et al.
Health Technology Assessment (Winchester, England)|October 23, 2009
Ustekinumab for the treatment of moderate to severe psoriasisE Gospodarevskaya, J Picot, K Cooper, et al.
Health Technology Assessment (Winchester, England)|October 4, 2008
Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic reviewA Takeda, E Loveman, P Harris, et al.
The Cochrane Database of Systematic Reviews|October 20, 2005
Surgery for morbid obesityJ Colquitt, A Clegg, E Loveman, et al.
Health Technology Assessment (Winchester, England)|September 19, 2003
The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluationE Loveman, C Cave, C Green, et al.
Health Technology Assessment (Winchester, England)|April 2, 2010
The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluationE Loveman, J Jones, D Hartwell, et al.
Health Technology Assessment (Winchester, England)|October 7, 2009
Gemcitabine for the treatment of metastatic breast cancerJ Jones, A Takeda, S C Tan, et al.
Health Technology Assessment (Winchester, England)|April 28, 2007
The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluationA L Takeda, J Jones, E Loveman, et al.
Health Technology Assessment (Winchester, England)|August 28, 2002
The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluationA J Clegg, J Colquitt, M K Sidhu, et al.
Health Technology Assessment (Winchester, England)|February 14, 2003
Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluationJ Bryant, E Loveman, D Chase, et al.
Pageof 4